Oxford Vaccine

Germany To Recommend Oxford Covid Vaccine For Over 65s: Angela Merkel

World News | Agence France-Presse | Thursday March 4, 2021

Germany will soon authorise the AstraZeneca/Oxford vaccine against Covid for people over the age of 65, Chancellor Angela Merkel said Wednesday.

Growing Evidence On Oxford Shot Should Guide Other Countries, Vaccine Chief Says

World News | Reuters | Tuesday March 2, 2021

Real-world data on the effectiveness of Oxford and AstraZeneca's COVID-19 vaccine in older people from its rollout in Britain should help inform decision making in other countries, Oxford Vaccine Group Director Andrew Pollard said on Tuesday.

Pfizer, Oxford Vaccines Reduce Severe COVID-19 In Elderly, UK Study Finds

World News | Press Trust of India | Tuesday March 2, 2021

The Pfizer and Oxford-AstraZeneca vaccines for COVID-19 are highly effective in reducing severe coronavirus infection among people aged 70 years and above, according to a study.

3-Month Gap Between Oxford Vaccine Jabs Gives Better Efficacy: Study

World News | Press Trust of India | Saturday February 20, 2021

A three-month interval between doses of the Oxford COVID-19 vaccine results in higher vaccine efficacy than a six-week gap, according to a new study which says the first dose can offer up to 76 per cent protection in the months between the two jabs.

Does World Need New Covid Vaccines? Oxford Vaccine Trial Chief Said This

World News | Reuters | Tuesday February 9, 2021

It is not yet clear whether or not the world needs a new set of vaccines to fight different variants of the novel coronavirus but scientists are working on new ones so there is no reason for alarm, the head of the Oxford Vaccine Group said on Tuesday.

In World First, Britain To Mix Pfizer And Oxford Vaccine Doses

World News | Reuters | Friday February 5, 2021

British researchers are to explore mixing doses of the Pfizer and AstraZeneca COVID-19 vaccines in a world first trial aimed at finding new ways to swiftly reduce coronavirus infections as new mutated variants emerge.

Oxford Vaccine Gives Good Immune Responses In Elderly, Says Trial Chief

World News | Reuters | Wednesday February 3, 2021

The COVID-19 vaccine developed by Oxford University and AstraZeneca gives good immune responses in older people, even if there is a lack of data about its exact efficacy, Oxford's vaccine trial chief Andrew Pollard said on Wednesday.

Covid Vaccines May Provide Protection Even As Variants Evolve: Oxford

World News | Reuters | Wednesday February 3, 2021

COVID-19 vaccines might offer protection against severe disease even as coronavirus variants evolve to better allow continued transmission between people, the head of the Oxford Vaccine Group Andrew Pollard said on Wednesday.

Oxford Kept UK Vaccine Volunteers In Dark On Dose Error: Report

World News | Reuters | Tuesday February 2, 2021

About 1,500 of the initial volunteers in a late-stage clinical trial of the Oxford/AstraZeneca COVID-19 vaccine were given the wrong dose, but weren't informed that a mistake had been made after the blunder was discovered, documents obtained by Reuters show.

Bolivia, Serum Institute Sign Deal For 5 Million Oxford Vaccine Doses

India News | Reuters | Wednesday January 13, 2021

The Bolivian government said on Wednesday it had signed a contract with Serum Institute for the supply of 5 million doses of AstraZeneca's COVID-19 vaccine.

Government Orders 11 Million Oxford Vaccine Doses At ₹ 200 Each

India News | Reported by Vishnu Som, Edited by Deepshikha Ghosh | Monday January 11, 2021

The Oxford vaccine is likely to be priced at Rs 200 a vial and the government may place an order today, sources from Adar Poonawalla's Serum Institute of India (SII) said today.

Oxford Vaccine At Rs. 1,000 If Centre Allows Us To Sell: Adar Poonawalla

India News | Reported by Vishnu Som, Edited by Anindita Sanyal | Monday January 4, 2021

The Serum Institute of India's Covishield vaccine, which has got approval from the country's drug regulator, will be commercially available at Rs 1,000 per dose if the government allows sale in retail, company chief Adar Poonawalla has said.

Coronavirus Highlights: 19,079 Fresh COVID-19 Cases In India

India News | Edited by Nonika Marwaha | Sunday January 3, 2021

India added 19,079 coronavirus infections in the past 24 hours, placing its overall number at 1.03 crore cases, the Health Ministry's data showed.

Oxford COVID-19 Vaccine Cleared By Expert Panel For India

India News | Reported by Sukirti Dwivedi, Edited by Debanish Achom | Saturday January 2, 2021

The Oxford COVID-19 vaccine manufactured by the Serum Institute of India will be sent for approval to the regulator Drugs Controller General of India (DCGI) by a government-appointed panel of experts.

US Expects To Approve UK-Backed AstraZeneca-Oxford Vaccine In April

World News | Agence France-Presse | Thursday December 31, 2020

The United States is expected to approve the low-cost AstraZeneca/Oxford vaccine in April, a senior official said, more than three months after Britain's green light on Wednesday.